Methyldopa Waymade (Methyldopa)

Methyldopa is an antihypertensive agent that acts on the central sympathetic nervous system to control elevated blood pressure.

• Essential hypertension: reduces systolic and diastolic pressure in patients with primary hypertension.
• Secondary hypertension: helps control blood pressure when caused by endocrine or renal disorders.
• Pregnancy‑induced hypertension: provides a safer option for managing high blood pressure during pregnancy.

• Methyldopa is metabolized to alpha‑methyldopamine, which stimulates central alpha‑2 adrenergic receptors in the medulla. Activation of these receptors decreases sympathetic outflow, reduces norepinephrine release, and leads to vasodilation and lowered peripheral vascular resistance, thereby lowering systemic blood pressure.

Methyldopa may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Dizziness: sensation of light‑headedness, especially when standing quickly.
• Headache: mild to moderate pain often reported during initiation.
• Fatigue: generalized tiredness that may affect daily activities.
• Dry mouth: reduced salivation causing oral discomfort.
• Nausea: upset stomach, sometimes with mild vomiting.

Serious or Rare Side Effects

• Hepatic dysfunction: elevated liver enzymes or jaundice requiring monitoring.
• Hemolytic anemia: destruction of red blood cells leading to fatigue and pallor.
• Severe hypotension: abrupt drop in blood pressure causing fainting.
• Stevens‑Johnson syndrome: rare skin reaction with blistering and mucosal involvement.
• Neuroleptic malignant‑like syndrome: rare but potentially life‑threatening condition with fever and muscle rigidity.

Methyldopa requires careful monitoring and patient education to minimize risks.

• Blood pressure monitoring: check regularly to avoid excessive hypotension.
• Liver function assessment: evaluate baseline enzymes and repeat if symptoms arise.
• Depression screening: monitor for mood changes, as central alpha‑2 activation can affect neurotransmitters.
• Cardiovascular disease caution: use cautiously in patients with coronary artery disease or heart failure.
• Drug‑induced lupus watch: be alert for rash, arthralgia, or fever.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Methyldopa can alter the effects of several other medicines, requiring clinician oversight.

Major Interactions (Avoid)

• MAO inhibitors: concurrent use may cause hypertensive crisis.
• Direct-acting sympathomimetics (e.g., epinephrine): may blunt their pressor effect.
• Antihypertensive combination therapy: risk of additive hypotension.

Moderate Interactions (Monitor Closely)

• CNS depressants (e.g., benzodiazepines): may increase sedation.
• Lithium: methyldopa can raise lithium levels, necessitating serum monitoring.
• Antidiabetic agents: blood glucose may be affected, requiring glucose checks.